Haibo Qiu

11PUBLICATIONS
35CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 05, 2026
Profiling Immune-Related Adverse Events Associated with Imatinib: A Two-Decade Real-World Safety Study Based on FDA Adverse Event Reporting System.

|May 05, 2026
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 Trial.

|Feb 12, 2026
Comparative Effectiveness and Modality-Dependent Prognostic Value of Pathological Response Following Neoadjuvant Therapy for Locally Advanced Gastric Cancer.

Yongfeng Zhu, Zhenchong Chen, Minju Jo

|Dec 09, 2025
Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial.

Jun Zhang, Yanqiao Zhang, Haibo Qiu

|Oct 30, 2025
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA.

Hui-Yan Luo, Wei Wei, Pansong Li

|Dec 11, 2024
Cancer situation in China: an analysis based on the global epidemiological data released in 2024.

Xiayao Diao, Chao Guo, Yukai Jin

Pageof 2

Frequent Collaborators

4 joint publications

Ruihua Xu

3 joint publications

Yuan-Fang Li

2 joint publications

Run-Cong Nie

2 joint publications

Feng Wang